ATLAB Pharma

Nantes, France Founded: 2008 • Age: 18 yrs Acquired By Telix Pharma
Radio-antibodies for cancer treatment are developed by ATLAB Pharma.
Request Access

About ATLAB Pharma

ATLAB Pharma is a company based in Nantes (France) founded in 2008 was acquired by Telix Pharma in September 2018.. ATLAB Pharma operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

  • Headquarter Nantes, France
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $7.94 M (USD), Grant

    Jun 02, 2009

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Telix Pharma

    (Sep 11, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ATLAB Pharma

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $7.9M
  • First Round

    (02 Jun 2009)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2009 Amount Grant - ATLAB Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ATLAB Pharma

ATLAB Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Telix Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Theranostic radiopharmaceuticals are developed for cancer imaging and therapy.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ATLAB Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ATLAB Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Atlab Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ATLAB Pharma

ATLAB Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Cancer therapies are developed using selective pathway inhibitors.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Atlab Pharma

Frequently Asked Questions about ATLAB Pharma

When was ATLAB Pharma founded?

ATLAB Pharma was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Where is ATLAB Pharma located?

ATLAB Pharma is headquartered in Nantes, France. It is registered at Nantes, Pays De La Loire, France.

What does ATLAB Pharma do?

ATLAB Pharma was founded in 2008 and is based in Nantes, France. Operations focus on the biotechnology sector, specifically radio immunotherapy for cancer. Monoclonal antibodies conjugated to radioisotopes are developed to deliver targeted radiation to tumor cells. The lead candidate, ATL101, targets prostate-specific membrane antigen using Lutetium-177 and has demonstrated safety and anti-tumor activity in Phase I and II trials for castrate-resistant prostate cancer.

Who are the top competitors of ATLAB Pharma?

ATLAB Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.

Who are ATLAB Pharma's investors?

ATLAB Pharma has 1 investor. Key investors include Telix Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available